Canada markets closed

Palantir Technologies Inc. (PLTR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
25.52+0.11 (+0.43%)
At close: 4:00PM EDT
25.65 +0.13 (+0.51%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close25.41
Bid25.64 x 3200
Ask25.65 x 3200
Day's Range25.25 - 26.75
52 Week Range9.85 - 45.00
Avg. Volume46,541,615
Market Cap49.844B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.79
Earnings DateNov. 10, 2021 - Nov. 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.76
  • Zacks

    Palantir Technologies Inc. (PLTR) Outpaces Stock Market Gains: What You Should Know

    Palantir Technologies Inc. (PLTR) closed at $25.52 in the latest trading session, marking a +0.43% move from the prior day.

  • Business Wire

    Palantir Announces Date of Third Quarter 2021 Earnings Release and Conference Call

    DENVER, October 26, 2021--Palantir Technologies Inc. (NYSE: PLTR) announced today that results for its third quarter ended September 30, 2021 will be released on Tuesday, November 9, 2021, prior to the open of U.S. markets. Palantir will host a conference call to discuss its results at 6:00 AM MT / 8:00 AM ET.

  • Motley Fool

    Got $5,000? These 2 Unstoppable Stocks Are No-Brainer Buys

    Abbott Laboratories (NYSE: ABT) and Palantir Technologies (NYSE: PLTR) are two suitable options for long-term investors. Healthcare giant Abbott Laboratories was a great buy before the pandemic and its business looks even better today. The healthcare company is performing incredibly well and is on track to blow past last year's revenue of $34.6 billion as it already has sales of $31.6 billion through the first nine months of 2021.